Sfoglia per Autore  ELENA, CHIARA

Opzioni
Mostrati risultati da 1 a 20 di 63
Titolo Data di pubblicazione Autore(i) File
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders 1-gen-2006 Rumi, Elisa; Passamonti, F; Pietra, D; DELLA PORTA, MATTEO GIOVANNI; Arcaini, Luca; Boggi, S; Elena, Chiara; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, Mario
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation 1-gen-2007 Passamonti, F; Randi, Ml; Rumi, Elisa; Pungolino, E; Elena, Chiara; Pietra, D; Scapin, M; Arcaini, Luca; Tezza, F; Moratti, Remigio; Pascutto, C; Fabris, F; Morra, E; Cazzola, Mario; Lazzarino, M.
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia 1-gen-2007 Rumi, Elisa; Passamonti, F; Zibellini, S; Martinetti, M; Arcaini, Luca; Elena, Chiara; Cazzola, Mario; Lazzarino, M.
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 1-gen-2007 Rumi, Elisa; Passamonti, Francesco; DELLA PORTA, MATTEO GIOVANNI; Elena, Chiara; Arcaini, Luca; Vanelli, L; DEL CURTO, Cecilia; Pietra, Daniela; Boveri, Emanuela; Pascutto, Cristiana; Cazzola, Mario; Lazzarino, Mario
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia 1-gen-2008 Castagnola, Carlo; Elena, Chiara; Merli, Michele
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 1-gen-2008 Boveri, E; Passamonti, F; Rumi, Elisa; Pietra, D; Elena, Chiara; Arcaini, Luca; Pascutto, C; Castello, Alessandro; Cazzola, Mario; Magrini, Umberto; Lazzarino, Mario
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 1-gen-2008 Passamonti, F; Rumi, Elisa; Arcaini, Luca; Boveri, E; Elena, Chiara; Pietra, C; Boggi, S; Astori, C; Bernasconi, Paolo; Varettoni, M; Brusamolino, E; Pascutto, C; Lazzarino, M.
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 1-gen-2008 Passamonti, Francesco; Rumi, Elisa; Caramella, M; Elena, Chiara; Arcaini, Luca; Boveri, E; Del Curto, C; Pietra, D; Vanelli, L; Bernasconi, Paolo; Pascutto, C; Cazzola, Mario; Morra, E; Lazzarino, Mario
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 1-gen-2009 Rumi, Elisa; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, Luca; Elena, Chiara; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, Remigio; Cazzola, Mario; Lazzarino, Mario
Blast phase of essential thrombocythemia: A single center study. 1-gen-2009 Passamonti, Francesco; Rumi, Elisa; Arcaini, Luca; Elena, Chiara; Castagnola, C; Zappasodi, P; Bernasconi, Paolo; Pietra, D; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 1-gen-2010 Rumi, Elisa; Passamonti, Francesco; Arcaini, Luca; Bernasconi, Paolo; Elena, Chiara; Pietra, D; Brisci, A; Arbustini, Eloisa; Cazzola, Mario; Lazzarino, Mario
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 1-gen-2010 Passamonti, Francesco; Rumi, Elisa; Pietra, D; Elena, Chiara; Boveri, E; Arcaini, Luca; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, Mario; Cazzola, Mario
Validation of cytogenetic-based risk stratification in primary myelofibrosis. 1-gen-2010 Rumi, Elisa; Passamonti, Francesco; Bernasconi, Paolo; Arcaini, Luca; Pietra, D; Elena, Chiara; Boveri, E; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. 1-gen-2010 Passamonti, Francesco; Rumi, Elisa; Elena, Chiara; Arcaini, Luca; Merli, M; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Mutational status of myeloproliferative neoplasms. 1-gen-2010 Rumi, Elisa; Elena, Chiara; Passamonti, Francesco
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm 1-gen-2011 Rumi, Elisa; Harutyunyan, A; Elena, Chiara; Pietra, D; Klampfl, T; Bagienski, K; Berg, T; Casetti, I; Pascutto, C; Passamonti, Francesco; Kralovics, R; Cazzola, Mario
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. 1-gen-2011 Passamonti, F; Elena, Chiara; Schnittger, S; Skoda, Rc; Green, Ar; Girodon, F; Kiladjian, Jj; Mcmullin, Mf; Ruggeri, M; Besses, C; Vannucchi, Am; Lippert, E; Gisslinger, H; Rumi, Elisa; Lehmann, T; Ortmann, Ca; Pietra, D; Pascutto, C; Haferlach, T; Cazzola, Mario
Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms 1-gen-2011 Pietra, D; Brisci, A; Rumi, Elisa; Boggi, S; Elena, Chiara; Pietrelli, A; Bordoni, R; Ferrari, M; Passamonti, F; De Bellis, G; Cremonesi, L; Cazzola, Mario
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS. 1-gen-2011 Elena, Chiara; Passamonti, F; Rumi, Elisa; Malcovati, Luca; Arcaini, Luca; Boveri, E; Merli, M; Pietra, D; Pascutto, C; Lazzarino, Mario
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. 1-gen-2011 Rumi, Elisa; Passamonti, F; Elena, Chiara; Pietra, D; Arcaini, Luca; Astori, C; Zibellini, S; Boveri, E; Pascutto, C; Lazzarino, Mario
Mostrati risultati da 1 a 20 di 63
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile